GC Biopharma wins $44 mn flu vaccine order from WHO agency

The S.Korean pharmaceutical company's vaccine will be supplied to eight Latin American countries

GC Biopharma wins mn flu vaccine order from WHO agency
Ji-Hyun Lee 1
2023-03-21 10:55:11 bluesky@hankyung.com
Bio & Pharma

South Korea's pharmaceutical firm GC Biopharma Corp. said on Monday that it has won a $44.3 million (57.9 billion won) order for flu vaccines in a drug tender offered by the Pan American Health Organization (PAHO), an arm of the World Health Organization (WHO).

Accordingly, GC's flu vaccine will be supplied to eight Latin American countries, including Honduras, Peru and Bolivia, in the first half of the year.

GC Biopharma's "GC flu quadrivalent" received WHO's prequalification (PQ) certification back in 2016. PQ is a certification for supplying vaccines to international relief organizations.

"With the expansion of quadrivalent flu vaccination overseas, we expect to see momentum in our sales growth and profitability going forward," said a company official.

Write to Ji-Hyun Lee at bluesky@hankyung.com
#GC Biopharma #Pan American Health Organization #PAHO #flu vaccines #prequalification certification #korea gc biopharma #gc-biopharma latin-america

GC Biopharma's licensed flu vaccine gets approval in Taiwan

GC Biopharma's licensed flu vaccine gets approval in Taiwan

South Korea's pharmaceutical firm GC Biopharma Corp. announced on Monday that its quadrivalent flu vaccine has received marketing approval from the Taiwanese Food and Drug Administration within the Ministry of Health and Welfare.The company licensed the vaccine to Medigen Vaccine Biologics Cor

GC Biopharma to develop mRNA flu vaccine with Canadian pharma

GC Biopharma to develop mRNA flu vaccine with Canadian pharma

South Korea's GC Biopharma Corp. announced on Thursday that it will start developing a flu vaccine based on messenger ribonucleic acid (mRNA).The drug maker said it has exercised an option contract with Acuitas Therapeutics, a Canadian pharma that specializes in lipid nano particle (LNP) deliv

GC Biopharma gets WHO pre-qualification approval for chickenpox vaccine

GC Biopharma gets WHO pre-qualification approval for chickenpox vaccine

South Korea's GC Biopharma Corp. is set to regain the No. 1 spot in global production of chickenpox vaccines after earning qualification to enter the World Health Organization (WHO) procurement market with Barycela following its export hit Suduvax. This breakthrough is expected to heat up glob

GC Biopharma, Sanofi to jointly market Plavix

GC Biopharma, Sanofi to jointly market Plavix

Plavix GC Biopharma Co. (formerly Green Cross Corp.) said on Monday it has entered into a joint sales partnership with Sanofi-Aventis Korea, the South Korean subsidiary of multinational pharmaceuticals company Sanofi, for Plavix 75 mg, an antiplatelet medication.The agreement calls for GC Bioph
(* comment hide *}